Loading...
Clinical endpoints for developing pharmaceuticals to manage patients with sporadic or genetic risk of colorectal cancer
To reduce the morbidity and mortality from colorectal cancer, current clinical practice focuses on screening for early detection and polypectomy as a form of secondary prevention, complemented with surgical interventions when appropriate. No pharmaceutical agent is currently approved for use in clin...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3587976/ https://ncbi.nlm.nih.gov/pubmed/22928902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/egh.12.23 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|